Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects.
Tremlett
Helen
H
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D015337:Multicenter Studies as Topic; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab